A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

The Journal of Immunology : Official Journal of the American Association of Immunologists
Chaofan LiBin Wang

Abstract

Respiratory syncytial virus (RSV) infection can cause severe disease in the lower respiratory tract of infants and older people. Vaccination with a formalin-inactivated RSV vaccine (FI-RSV) and subsequent RSV infection has led to mild to severe pneumonia with two deaths among vaccinees. The vaccine-enhanced disease (VED) was recently demonstrated to be due to an elevated level of Th2 cell responses following loss of regulatory T (Treg) cells from the lungs. To induce high levels of neutralizing Abs and minimize pathogenic T cell responses, we developed a novel strategy of immunizing animals with a recombinant RSV G protein together with cyclosporine A. This novel vaccine induced not only a higher level of neutralizing Abs against RSV infection, but, most importantly, also significantly higher levels of Treg cells that suppressed VED in the lung after RSV infection. The induced responses provided protection against RSV challenge with no sign of pneumonia or bronchitis. Treg cell production of IL-10 was one of the key factors to suppress VED. These finding indicate that G protein plus cyclosporine A could be a promising vaccine against RSV infection in children and older people.

References

Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B E BiererS L Schreiber
Mar 17, 1988·The New England Journal of Medicine·P F BougneresJ L Chaussain
Sep 1, 1988·The Journal of Experimental Medicine·M J CannonB A Askonas
Jan 1, 1994·The Journal of Clinical Investigation·Y Levy, J C Brouet
Sep 1, 1996·Clinical Immunology and Immunopathology·S HoG R Crabtree
Nov 30, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·W Y Almawi, O K Melemedjian
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·G ZenkeT Fehr
Jul 31, 2001·Nature Immunology·R A TrippL J Anderson
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Qing HuaiHengming Ke
Sep 18, 2002·The Journal of Experimental Medicine·Fernando P PolackRuth A Karron
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroyuki MatsueAkira Takashima
Jun 7, 2003·Journal of Autoimmunity·Oliver AnnackerFiona Powrie
Aug 13, 2004·European Journal of Immunology·Maurus de la RosaAlexander Scheffold
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·John ColganJeremy Luban
Jun 4, 2005·Clinical and Experimental Immunology·E L BatakiM L Everard
Jul 16, 2005·Clinical Microbiology Reviews·Peter J M Openshaw, John S Tregoning
Jan 19, 2006·Blood·Dong-Mei ZhaoEthan M Shevach
Jun 1, 2006·Clinical and Experimental Immunology·C A LindemansL Koenderman
Sep 28, 2006·Reviews in Medical Virology·S van Drunen Littel-van den HurkJ Kovacs-Nolan
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel P BeitingJudith A Appleton
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anthony JoethamErwin W Gelfand
Jun 6, 2007·The Journal of Experimental Medicine·Blythe D SatherDaniel J Campbell
Jul 17, 2007·Vaccine·Shree R SinghEddie G Moore

❮ Previous
Next ❯

Citations

Mar 10, 2017·International Journal of Molecular Sciences·Emma Rey-Jurado, Alexis M Kalergis
Jul 20, 2017·Immunology and Cell Biology·Takehiko Shibata, Manabu Ato
Feb 26, 2020·Pathogens·Daniela Ogonczyk MakowskaGuy Boivin
Aug 4, 2020·Antiviral Chemistry & Chemotherapy·Elena Margret ThornhillDavid Verhoeven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.